Crosby, J, Peloso, GM, Auer, PL, Crosslin, DR, Stitziel, NO, Lange, LA, Lu, Y, Tang, ZZ, Zhang, H, Hindy, G, Masca, N, Stirrups, K, Kanoni, S, Do, R, Jun, G, Hu, Y, Kang, HM, Xue, C, Goel, A, Farrall, M, Duga, S, Merlini, PA, Asselta, R, Girelli, D, Olivieri, O, Martinelli, N, Yin, W, Reilly, D, Speliotes, E, Fox, CS, Hveem, K, Holmen, OL, Nikpay, M, Farlow, DN, Assimes, TL, Franceschini, N, Robinson, J, North, KE, Martin, LW, DePristo, M, Gupta, N, Escher, SA, Jansson, JH, Van Zuydam, N, Palmer, CNA, Wareham, N, Koch, W, Meitinger, T, Peters, A, Lieb, W, Erbel, R
, Konig, IR, Kruppa, J, Degenhardt, F, Gottesman, O, Bottinger, EP, O'Donnell, CJ, Psaty, BM, Ballantyne, CM, Abecasis, G, Ordovas, JM, Melander, O, Watkins, H, Orho-Melander, M, Ardissino, D, Loos, RJF, McPherson, R, Willer, CJ, Erdmann, J, Hall, AS, Samani, NJ, Deloukas, P, Schunkert, H, Wilson, JG, Kooperberg, C, Rich, SS, Tracy, RP, Lin, DY, Altshuler, D, Gabriel, S, Nickerson, DA, Jarvik, GP, Cupples, LA, Reiner, AP, Boerwinkle, E & Kathiresan, S 2014, '
Loss-of-function mutations in APOC3, triglycerides, and coronary disease',
New England Journal of Medicine, Jg. 371, Nr. 1, S. 22-31.
https://doi.org/10.1056/NEJMoa1307095